Here are relevant reports on : multiple-sclerosis-disease-modifying-therapies-market
-
Electronic Drug Delivery Systems Market by Type (Electronic Wearable Infusion Pump, Autoinjectors, Injection Pens, Electronic Inhalers), Indication (Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD) - Global Forecast to 2024
The electronic drug delivery system market is expected to grow from USD 7.8 billion in 2019 to USD 11.9 billion by 2024, at a compound annual growth rate (CAGR) of 8.7%. during the forecast period.The prominent players in the electronic drug delivery systems market are Insulet Corporation (US), Bayer AG (Germany), Medtronic (Ireland), Novo Nordisk A/S (Denmark), Companion Medical (US), F.Hoffmann-La Roche Ltd (Switzerland), United Therapeutics Corporation (US), AstraZeneca (UK), Tandem Diabetes Care (US), Merck Group (Germany), and Amgen (US).
- Published: October 2019
- Price: $ 4950
- TOC Available:
-
US Therapeutic Plasma Exchange Market by Product (Devices, Consumables), Technology (Centrifugation, Membrane Separation), Procedures & Patients (Guillain Syndrome, Multiple Sclerosis, Cryoglobulinemia), End Users & Region - Forecast to 2025
The US therapeutic plasma exchange (TPE) market, valued at $178 million in 2020, is projected to grow to $243 million by 2025, with a CAGR of 6.3%. Growth is fueled by increasing chronic disease prevalence and technological advancements, especially in continuous-flow centrifugation. However, high device costs and a shortage of skilled professionals may hinder growth.
- Published: September 2020
- Price: $ 4950
- TOC Available:
-
Anti Nicotine Therapies (2010 - 2015)
Smoking cessation products are gaining popularity in both OTC and prescription products market segments. Increasing burden on healthcare system due to deteriorating quality of life because of smoking and several side effects associated with the current smoking cessation marketed products, builds up the need of novel products with better efficacy in this market.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Minimal Residual Disease Market by Product (Kits, Instruments), Technology (PCR, NGS), Application (Leukemia, Lymphoma, Multiple Myeloma, Solid Tumors), End User (Hospitals, Diagnostic Labs, Research Institutes), & Region - Global Forecast to 2029
The global minimal residual disease testing market, valued at US$1.27 billion in 2023, stood at US$1.43 billion in 2024 and is projected to advance at a resilient CAGR of 12.2% from 2024 to 2029, culminating in a forecasted valuation of US$2.55 billion by the end of the period. The market is driven by the growing prevalence of cancer globally and increasing funding from international organizations and governments for cancer prevention programs.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Railway Connectors Market by Application (Diesel Multiple Units (DMUs), Electric Multiple Units (EMUs), Light Rails/Trams, Subways/Metros, Passenger Coaches), Platform, Component, Connector Type, and Region - Global Forecast to 2023
The railway connectors market is expected to grow from USD 802 million in 2018 to USD 1,069 million by 2023, at a Compound Annual Growth Rate (CAGR) of 5.92% during the forecast period. Increased demand for different types of wagons is a major factor driving the growth of the railway connectors market. Wagons are rail vehicles used to carry passengers and freights. These vehicles are not equipped with propulsion systems and hence, are drawn by locomotives. The demand for wagons is continuously growing in countries such as the US, the UK, France, etc., due to increased industrial activities. Major vendors in the railway connectors market include are TE Connectivity (Switzerland), Amphenol Corporation (US), Molex Incorporated (US), ITT (US), Smiths Interconnect (US), Fischer Connectors (Switzerland), Esterline Technologies (US), Schaltbau (Germany), and Sichuan Yonggui Science and Technology (China).
- Published: December 2018
- Price: $ 4950
- TOC Available:
-
Global Multiple Myeloma Drugs Market
2008 saw almost 12 million patients diagnosed with cancer. Despite, increasing technological advancements and research the deaths due to cancer were about 8 million people in 2008. Lung cancer accounts for the highest mortality rate. There has been a significant development in technologies and drugs/vaccines with respect to breast cancer, thyroid cancer, and pancreatic cancer therefore increasing the survival rates.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Smart Antenna Market: Adaptive Array Antennas, Multiple Antennas, MIMO - Global Forecast and Analysis (2012 - 2017)
A smart antenna is a digital wireless communications antenna system that takes advantage of diversity effect at the transmitter, the receiver, or both. Diversity effect involves the transmission and/or reception of multiple radio frequency (RF) waves to increase data speed and reduce the error rate.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Gyros FOG / RLG Market (Single Axis, Multiple Axis), By Products, Technology, Application & Geography - 2019
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Poultry Medicine/Pharmaceuticals Market by Animal Type (Chickens, Turkeys, Ducks), Product (Drugs, Vaccines, Feed Additives), Disease Indication (Newcastle disease, Infectious Bursal Disease, Salmonella), Route of Administration - Global Forecast to 2029
The global poultry medicine/pharmaceuticals market, valued at US$4.73 billion in 2023, stood at US$5.01 billion in 2024 and is projected to advance at a resilient CAGR of 5.9% from 2024 to 2029, culminating in a forecasted valuation of US$6.68 billion by the end of the period. The growth of the poultry medicine/pharmaceutical industry can be attributed to the rising global population and consumption of poultry meat and eggs leading to more poultry farming practiced notably in the developing regions where poultry is the cheapest source of protein.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Bioresorbable Vascular Scaffold Market by Type (Metal, Polymer), Application (Coronary Artery Disease, Peripheral Artery Disease), End User (Hospitals) and Geography – Global Forecast to 2027
The global bioresorbable vascular scaffold market size is projected to reach ~USD 75 million by 2027 from ~USD 50 million in 2022, at a CAGR of 8.5% during the forecast period. The market is driven by factors such as rapidly increasing geriatric population and the risk of coronary artery diseases and peripheral artery diseases. On the other hand, product failures and withdrawals are expected to limit market growth to a certain extent in the coming years.
- Published: November 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
